Leukemia Clinical Trials in Detroit

Showing 1141-1160 of 1,440 trials

Inhaled Nitric Oxide for Preterm Infants With Severe Respiratory Failure

NCT00016523

This multicenter trial tested whether inhaled nitric oxide would reduce death or the need for oxygen in preterm infants (less than 34 weeks gestational age) with severe lung disease.

Infant, NewbornInfant, Low Birth WeightInfant, Small for Gestational Age+5 more

NICHD Neonatal Research Network420 participantsStarted Jan 2001

Birmingham, Alabama, United States • Palo Alto, California, United States • San Diego, California, United States +14 more locations

COMPLETEDPhase 2/3< 1 mile

The Effects of Erythropoietin (EPO) on the Transfusion Requirements of Very Low Birth Weight Infants

NCT01203514

This study tested the safety and efficacy of transfusing erythropoietin (Epo) and iron in infants of \<1,250g birth weight. For infants 401-1,000g birth weight, we tested whether early erythropoietin (Epo) and iron therapy would decrease the number of transfusions received. For infants 1,001-1,250g birth weight, we tested whether early erythropoietin (Epo) and iron therapy would decrease the percentage of infants who received any transfusions.

Infant, NewbornInfant, Low Birth WeightInfant, Small for Gestational Age+2 more

NICHD Neonatal Research Network318 participantsStarted Aug 1997

New Haven, Connecticut, United States • Washington D.C., District of Columbia, United States • Atlanta, Georgia, United States +6 more locations

Inhaled Nitric Oxide for Preterm Infants With Severe Respiratory Failure

The Effects of Erythropoietin (EPO) on the Transfusion Requirements of Very Low Birth Weight Infants

Leukemia Trials in Other Cities

Physiologic Definition of Bronchopulmonary Dysplasia

Trametinib or Combination Chemotherapy in Treating Patients With Refractory or Advanced Biliary or Gallbladder Cancer or That Cannot Be Removed by Surgery

MRD Testing Before and After Hematopoietic Cell Transplantation for Pediatric Acute Myeloid Leukemia

S0802 - Topotecan With or Without Aflibercept in Treating Patients With Extensive-Stage Small Cell Lung Cancer

Clinical Study With Blinatumomab in Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL)

Temozolomide or Selumetinib in Treating Patients With Metastatic Melanoma of the Eye

Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia

Bendamustine Hydrochloride (HCl) in Indolent Non-Hodgkin's Lymphoma That Has Progressed During or Following Treatment With a Rituximab Regimen or Previously Untreated Chronic Lymphocytic Leukemia

Baclofen-Amitriptyline Hydrochloride-Ketamine Gel in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer

Multicenter Study of Pacritinib Combined With Ibrutinib in Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)

Study to Test the Benefit and Safety of GM-CT-01 in Combination With 5-FU to Treat Bile Duct and Gall Bladder Cancer

OPT-821 With or Without Vaccine Therapy in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer in Second or Third Complete Remission

Anamorelin HCl in the Treatment of Non-Small Cell Lung Cancer-Cachexia (NSCLC-C): An Extension Study (ROMANA 3)

Delayed Cord Clamping in VLBW Infants

Akt Inhibitor MK2206, Bendamustine Hydrochloride, and Rituximab in Treating Patients With Relapsed Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Safety and Efficacy Study of PRI-724 in Subjects With Advanced Myeloid Malignancies

PKC412 in Participants With Acute Myeloid Leukemia or With Myelodysplastic Syndrome (CPKC412A2104 Core); and PKC412 in Participants With Acute Myeloid Leukemia or With Myelodysplastic Syndrome With Either Wild Type or Mutated FMS-like Tyrosine Kinase 3 (FLT3) (CPKC412A2104E1 and CPKC412A2104E2)

Evaluating a Novel Onco-genetic BRCA Testing Counselling Model Among Patients With Ovarian Cancer

Other Conditions in Detroit